Even compared to its immediate weight problems/ diabetes therapy pharmaceutical peer, LLY at FWD P/E valuations of fifty eight.71x Together with the projected adj EPS growth at a CAGR of +sixty five.four% via FY2026, it https://ellaaqsb225473.ampedpages.com/5-essential-elements-for-where-can-find-wegovy-in-stock-56492594